India removes cap from patented rare disease drugs

India’s Department of Pharmaceuticals (DoP) has removed a price cap from a range of essential patented drugs used in the treatment of rare diseases.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Asia-Pacific

Indian court rules in Sanofi’s favour in trademark suit

21 November 2018 The Delhi High Court has ruled against a company for its ‘near identical’ imitation of pharmaceutical company Sanofi’s name and trademarks.

Asia

Pharma group asks USTR to drop India from watch list

12 February 2019 The lobby group for India’s pharma industry has asked the US Trade Representative office to remove India from its Priority Watch List of places that have weak enforcement of intellectual property laws.

More on this story

Asia-Pacific

Indian court rules in Sanofi’s favour in trademark suit

21 November 2018 The Delhi High Court has ruled against a company for its ‘near identical’ imitation of pharmaceutical company Sanofi’s name and trademarks.

Asia

Pharma group asks USTR to drop India from watch list

More on this story

Asia-Pacific

Indian court rules in Sanofi’s favour in trademark suit

21 November 2018 The Delhi High Court has ruled against a company for its ‘near identical’ imitation of pharmaceutical company Sanofi’s name and trademarks.

Asia

Pharma group asks USTR to drop India from watch list